Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor beta | 21 | 2024 | 24 | 5.210 |
Why?
|
| Prostate | 6 | 2021 | 10 | 1.040 |
Why?
|
| Receptors, Androgen | 6 | 2021 | 14 | 0.960 |
Why?
|
| Liver X Receptors | 11 | 2022 | 18 | 0.950 |
Why?
|
| Animals | 28 | 2023 | 1817 | 0.900 |
Why?
|
| Signal Transduction | 9 | 2021 | 225 | 0.870 |
Why?
|
| Sequence Deletion | 2 | 2020 | 6 | 0.810 |
Why?
|
| Mice | 20 | 2023 | 719 | 0.720 |
Why?
|
| Mammary Glands, Animal | 2 | 2020 | 5 | 0.720 |
Why?
|
| Mice, Knockout | 17 | 2023 | 143 | 0.690 |
Why?
|
| Benzopyrans | 6 | 2024 | 11 | 0.660 |
Why?
|
| Phenotype | 1 | 2020 | 73 | 0.660 |
Why?
|
| Estrogen Receptor alpha | 8 | 2021 | 22 | 0.660 |
Why?
|
| Cholesterol | 2 | 2016 | 18 | 0.600 |
Why?
|
| Prostatic Neoplasms | 4 | 2021 | 21 | 0.600 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2024 | 11 | 0.560 |
Why?
|
| Orphan Nuclear Receptors | 5 | 2015 | 10 | 0.520 |
Why?
|
| Estrogens | 4 | 2021 | 21 | 0.510 |
Why?
|
| Male | 19 | 2021 | 2770 | 0.510 |
Why?
|
| Dehydroepiandrosterone | 1 | 2014 | 1 | 0.470 |
Why?
|
| Ligands | 4 | 2021 | 55 | 0.460 |
Why?
|
| Female | 16 | 2021 | 2816 | 0.450 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 107 | 0.410 |
Why?
|
| Humans | 16 | 2024 | 5485 | 0.410 |
Why?
|
| Drug Discovery | 2 | 2021 | 17 | 0.350 |
Why?
|
| Bile Acids and Salts | 2 | 2018 | 9 | 0.290 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 27 | 0.270 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 39 | 0.270 |
Why?
|
| Gene Expression | 4 | 2019 | 52 | 0.250 |
Why?
|
| Astrocytes | 3 | 2021 | 16 | 0.250 |
Why?
|
| Androgens | 3 | 2020 | 10 | 0.250 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2016 | 2 | 0.230 |
Why?
|
| Splicing Factor U2AF | 1 | 2024 | 2 | 0.230 |
Why?
|
| Alternative Splicing | 1 | 2024 | 5 | 0.230 |
Why?
|
| Neurons | 4 | 2022 | 131 | 0.220 |
Why?
|
| Colitis | 1 | 2023 | 1 | 0.220 |
Why?
|
| Biomarkers | 3 | 2018 | 87 | 0.220 |
Why?
|
| Down-Regulation | 3 | 2021 | 16 | 0.210 |
Why?
|
| Transcriptome | 2 | 2021 | 47 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 77 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 55 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 6 | 2023 | 195 | 0.200 |
Why?
|
| Spiral Ganglion | 1 | 2022 | 1 | 0.200 |
Why?
|
| Ki-67 Antigen | 2 | 2020 | 3 | 0.200 |
Why?
|
| Epithelium | 2 | 2020 | 9 | 0.200 |
Why?
|
| Nerve Degeneration | 2 | 2019 | 8 | 0.200 |
Why?
|
| Hearing Loss | 1 | 2022 | 10 | 0.200 |
Why?
|
| History, 21st Century | 1 | 2021 | 10 | 0.190 |
Why?
|
| History, 20th Century | 1 | 2021 | 13 | 0.190 |
Why?
|
| Research | 1 | 2021 | 10 | 0.190 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2021 | 10 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2020 | 69 | 0.190 |
Why?
|
| Brain | 3 | 2015 | 286 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2020 | 35 | 0.190 |
Why?
|
| Prostatic Hyperplasia | 1 | 2021 | 3 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 16 | 0.180 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 2 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 14 | 0.180 |
Why?
|
| Chemokines | 1 | 2020 | 3 | 0.170 |
Why?
|
| Stromal Cells | 1 | 2020 | 6 | 0.170 |
Why?
|
| Hyperplasia | 1 | 2020 | 4 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 11 | 0.170 |
Why?
|
| Trans-Activators | 1 | 2020 | 19 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 9 | 0.170 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 23 | 0.170 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 14 | 0.170 |
Why?
|
| Inflammation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Eye Proteins | 1 | 2020 | 36 | 0.160 |
Why?
|
| Optic Nerve | 1 | 2019 | 9 | 0.160 |
Why?
|
| RNA, Messenger | 1 | 2020 | 69 | 0.160 |
Why?
|
| Adipose Tissue, White | 2 | 2016 | 6 | 0.160 |
Why?
|
| Immunohistochemistry | 6 | 2016 | 30 | 0.160 |
Why?
|
| Protein Isoforms | 1 | 2019 | 16 | 0.160 |
Why?
|
| Immunity | 1 | 2019 | 9 | 0.160 |
Why?
|
| Antibodies | 1 | 2019 | 28 | 0.160 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2018 | 2 | 0.150 |
Why?
|
| Neutrophil Infiltration | 1 | 2018 | 3 | 0.150 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 4 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2018 | 5 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2018 | 8 | 0.150 |
Why?
|
| Dentate Gyrus | 1 | 2018 | 6 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2018 | 13 | 0.150 |
Why?
|
| Retina | 1 | 2019 | 130 | 0.150 |
Why?
|
| Central Nervous System | 2 | 2016 | 8 | 0.140 |
Why?
|
| Neoplasms | 1 | 2019 | 99 | 0.140 |
Why?
|
| Cytochrome P450 Family 4 | 1 | 2017 | 1 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 7 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 90 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 9 | 0.140 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2016 | 1 | 0.140 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2016 | 1 | 0.140 |
Why?
|
| Adipose Tissue, Brown | 1 | 2016 | 3 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 20 | 0.140 |
Why?
|
| Oxysterols | 1 | 2016 | 2 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 11 | 0.140 |
Why?
|
| Receptors, Notch | 1 | 2016 | 1 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2016 | 14 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 7 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 72 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 12 | 0.130 |
Why?
|
| Lipids | 1 | 2016 | 21 | 0.130 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2016 | 2 | 0.130 |
Why?
|
| Formaldehyde | 1 | 2016 | 2 | 0.130 |
Why?
|
| Microglia | 2 | 2013 | 11 | 0.130 |
Why?
|
| Lung | 1 | 2016 | 42 | 0.130 |
Why?
|
| Pain Measurement | 1 | 2016 | 17 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2015 | 3 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2021 | 7 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2015 | 20 | 0.130 |
Why?
|
| Mitochondria | 1 | 2015 | 23 | 0.120 |
Why?
|
| Pain | 1 | 2016 | 40 | 0.120 |
Why?
|
| Aging | 1 | 2017 | 127 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2012 | 6 | 0.120 |
Why?
|
| Anxiety | 2 | 2021 | 173 | 0.120 |
Why?
|
| Response Elements | 1 | 2015 | 2 | 0.120 |
Why?
|
| Exons | 1 | 2015 | 2 | 0.120 |
Why?
|
| Obesity | 1 | 2016 | 118 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2014 | 12 | 0.120 |
Why?
|
| Adrenal Cortex | 1 | 2014 | 1 | 0.120 |
Why?
|
| Steroids | 1 | 2014 | 1 | 0.120 |
Why?
|
| Zona Glomerulosa | 1 | 2014 | 1 | 0.120 |
Why?
|
| Zona Reticularis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 2014 | 2 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 1 | 0.110 |
Why?
|
| Hydroxycholesterols | 1 | 2013 | 2 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 5 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2020 | 120 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 1 | 0.110 |
Why?
|
| Macrophages | 3 | 2022 | 29 | 0.100 |
Why?
|
| Substantia Nigra | 1 | 2012 | 1 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 36 | 0.100 |
Why?
|
| Parkinsonian Disorders | 1 | 2012 | 3 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 1 | 2012 | 2 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 48 | 0.100 |
Why?
|
| Dopaminergic Neurons | 1 | 2012 | 22 | 0.100 |
Why?
|
| Urinary Bladder Calculi | 1 | 2012 | 1 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2012 | 2 | 0.100 |
Why?
|
| Dendritic Spines | 1 | 2012 | 3 | 0.100 |
Why?
|
| Uric Acid | 1 | 2012 | 2 | 0.100 |
Why?
|
| Apoptosis | 3 | 2018 | 55 | 0.090 |
Why?
|
| Androgen Antagonists | 2 | 2021 | 5 | 0.090 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2010 | 1 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 53 | 0.080 |
Why?
|
| Protein Binding | 2 | 2024 | 118 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2023 | 4 | 0.080 |
Why?
|
| Fatty Acids | 2 | 2021 | 11 | 0.080 |
Why?
|
| Biopsy | 2 | 2021 | 14 | 0.080 |
Why?
|
| Neuroglia | 2 | 2019 | 9 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 175 | 0.080 |
Why?
|
| Cell Movement | 2 | 2020 | 64 | 0.060 |
Why?
|
| Homeostasis | 2 | 2016 | 30 | 0.060 |
Why?
|
| Sex Factors | 2 | 2016 | 81 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 13 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2015 | 81 | 0.060 |
Why?
|
| Binding Sites | 1 | 2024 | 69 | 0.060 |
Why?
|
| Dextran Sulfate | 1 | 2023 | 1 | 0.050 |
Why?
|
| Colon | 1 | 2023 | 8 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2023 | 27 | 0.050 |
Why?
|
| Models, Biological | 2 | 2016 | 131 | 0.050 |
Why?
|
| Glutamates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Cochlea | 1 | 2022 | 4 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2021 | 1 | 0.050 |
Why?
|
| Calcitriol | 1 | 2021 | 3 | 0.050 |
Why?
|
| Tretinoin | 1 | 2021 | 3 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 5 | 0.050 |
Why?
|
| Wnt Proteins | 1 | 2021 | 9 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 19 | 0.050 |
Why?
|
| Androstenes | 1 | 2021 | 1 | 0.050 |
Why?
|
| Phenylthiohydantoin | 1 | 2021 | 1 | 0.050 |
Why?
|
| Finasteride | 1 | 2021 | 1 | 0.050 |
Why?
|
| Phytoestrogens | 1 | 2021 | 1 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 2 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 14 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 3 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2021 | 6 | 0.050 |
Why?
|
| Benzamides | 1 | 2021 | 5 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 14 | 0.050 |
Why?
|
| Aged | 2 | 2016 | 860 | 0.050 |
Why?
|
| Nitriles | 1 | 2021 | 11 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2021 | 16 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 8 | 0.040 |
Why?
|
| Middle Aged | 2 | 2016 | 1100 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 131 | 0.040 |
Why?
|
| Aquaporin 4 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2019 | 2 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 18 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 59 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 96 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2018 | 4 | 0.040 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 14 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 22 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 18 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 28 | 0.040 |
Why?
|
| Neutrophils | 1 | 2018 | 19 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2018 | 23 | 0.040 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 100 | 0.040 |
Why?
|
| Stem Cells | 1 | 2018 | 33 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 41 | 0.040 |
Why?
|
| Chemokine CXCL16 | 1 | 2017 | 1 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2017 | 1 | 0.040 |
Why?
|
| Smad7 Protein | 1 | 2017 | 1 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Clusterin | 1 | 2017 | 2 | 0.040 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2017 | 2 | 0.040 |
Why?
|
| Keratins | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2018 | 75 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2017 | 9 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2017 | 13 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 9 | 0.030 |
Why?
|
| Aromatase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Spermatocytes | 1 | 2016 | 1 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 35 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2016 | 15 | 0.030 |
Why?
|
| Germ Cells | 1 | 2016 | 6 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 8 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 7 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 75 | 0.030 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2016 | 3 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 12 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 15 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 16 | 0.030 |
Why?
|
| Pneumonia | 1 | 2016 | 20 | 0.030 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2015 | 1 | 0.030 |
Why?
|
| Body Composition | 1 | 2015 | 16 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 21 | 0.030 |
Why?
|
| Rats | 1 | 2017 | 251 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 55 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2015 | 3 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 6 | 0.030 |
Why?
|
| Ovary | 1 | 2015 | 3 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 30 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 242 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 13 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 23 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 65 | 0.030 |
Why?
|
| Carcinoma, Lobular | 1 | 2014 | 1 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 9 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 9 | 0.030 |
Why?
|
| Breast | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 11 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 350 | 0.030 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 1 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 1 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2013 | 12 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2013 | 11 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 8 | 0.030 |
Why?
|
| Benzoates | 1 | 2012 | 6 | 0.030 |
Why?
|
| Benzylamines | 1 | 2012 | 8 | 0.030 |
Why?
|
| Fear | 1 | 2012 | 8 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 321 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 5 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 11 | 0.020 |
Why?
|
| Maze Learning | 1 | 2012 | 27 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 14 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2012 | 11 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 55 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 67 | 0.020 |
Why?
|
| Receptors, Lipoprotein | 1 | 2010 | 1 | 0.020 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 37 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 176 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 806 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 1687 | 0.020 |
Why?
|